Search - tctmd.com

Displaying 301 - 320 of 946

Sort: Relevancy | Date

News Daily News

CHOICE a 1 Año: Sapien y CoreValve Ofrecen Resultados Clínicos Parecidos

August 11, 2015

News Industry News

Sorin Group Obtains Health Canada Approval for Perceval, Its Next Generation Sutureless Valve

August 05, 2015

News Industry News

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

July 29, 2015

News Industry News

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

July 27, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Daily News

MVARC文件提供了二尖瓣治疗研究的模板

Todd Neale

July 16, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral

Todd Neale

July 16, 2015

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Yael L. Maxwell

July 15, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

Advertisement

CHOICE a 1 Año: Sapien y CoreValve Ofrecen Resultados Clínicos Parecidos

Sorin Group Obtains Health Canada Approval for Perceval, Its Next Generation Sutureless Valve

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

MVARC文件提供了二尖瓣治疗研究的模板

MVARC Document Offers Template for Mitral Valve Therapeutics Research

El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content